Non-Paxlovid Rebound; Pandemic Spike in Early Puberty; New Therapy for Nightmares?


Note that some links may require subscriptions.

Outpatient COVID treatment with nirmatrelvir-ritonavir (Paxlovid) was 36% and 30% lower for Black and Hispanic patients compared with white patients, a CDC report found.

A high proportion of recovered COVID patients who didn’t take nirmatrelvir-ritonavir also experience symptom rebound. (JAMA Network Open)

Continuing on a downward trend, yearly cancer death rates dropped by 2.1% from 2015 to 2019, with the steepest drops seen for lung cancer and melanoma. There was also an increase in pancreatic cancer survival, according to the National Cancer Institute’s latest annual report.

Reversing recent trends, global tuberculosis (TB) cases rose by 4.5% from 2020 to 2021, the World Health Organization warned, including a 3% rise in drug-resistant TB.

The number of kids diagnosed with precocious puberty spiked during the pandemic — but why? (The New Yorker)

An estimated 15% of people who test positive for SARS-CoV-2 develop long COVID. (JAMA Network Open)

Speaking of long COVID, the NIH chose nirmatrelvir-ritonavir to test first as a possible long COVID treatment in a randomized, placebo-controlled trial of 1,700 participants. (Reuters)

China is now rolling out its inhalable COVID-19 vaccine. (Reuters)

Walgreens said its will no longer judge pharmacist performance based on speed. (NBC News)

Should states funnel money received from opioid settlements back into addiction programs? (STAT)

Oregon could be the very first state to make affordable healthcare a human right after the measure got added to the November ballot. (AP)

Hear how a man with prostate cancer received a $73,812 bill for the two shots of a drug invented back in 1973. (Kaiser Health News)

Researchers say that paring imagery rehearsal therapy with an associated sound during REM sleep with targeted memory reactivation may be more effective for treating nightmare disorder. (Current Biology)

Shelves across the nation still haven’t fully recovered from the baby formula shortage earlier this year. (NPR)

Following the Pennsylvania Senate debate on Tuesday, stroke survivors are finding kinship with Democratic candidate John Fetterman. (NBC News)

Yet another woman came forward claiming the Republican Georgia Senate nominee Herschel Walker pressured her into having an abortion. (NPR)

Genentech’s injectable faricimab (Vabysmo) succeeded in two phase III studies, achieving non-inferiority compared with aflibercept injections for treating macular edema from branch and central retinal vein occlusion.

The nightly eye drop NVK002 was effective for treating myopia progression in children in the 3-year phase III CHAMP study, developer Vyluma reported.

With a phase III flop, GSK is tossing out plans to push forward with its investigational monoclonal antibody otilimab for moderate-to-severe arthritis.

An Iranian man referred to as the “world’s dirtiest man” died at age 94 reportedly not long after his first bath in 60 years. (USA Today)

  • author['full_name']

    Kristen Monaco is a staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.



Source link

Ozinize
Logo
Shopping cart